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Abstract: In vivo surface imaging of ﬂuorescently labeled vasculature has
become a widely used tool for functional brain imaging studies. Techniques
such as phosphorescence quenching for oxygen tension measurements
and indocyanine green ﬂuorescence for vessel perfusion monitoring rely
on surface measurements of vascular ﬂuorescence. However, the depth
dependence of the measured ﬂuorescence signals has not been modeled
in great detail. In this paper, we investigate the depth dependence of the
measured signals using a three-dimensional Monte Carlo model combined
with high resolution vascular anatomy. We found that a bulk-vascularization
assumption to modeling the depth dependence of the signal does not provide
an accurate picture of penetration depth of the collected ﬂuorescence signal
in most cases. Instead the physical distribution of microvasculature, the
degree of absorption difference between extravascular and intravascular
space, and the overall difference in absorption at the excitation and
emission wavelengths must be taken into account to determine the depth
penetration of the ﬂuorescence signal. Additionally, we found that using
targeted illumination can provide for superior surface vessel sensitivity
over wide-ﬁeld illumination, with small area detection offering an even
greater amount of sensitivity to surface vasculature. Depth sensitivity
can be enhanced by either increasing the detector area or increasing the
illumination area. Finally, we see that excitation wavelength and vessel size
can affect intra-vessel sampling distribution, as well as the amount of signal
that originates from inside the vessel under targeted illumination conditions.
© 2011 Optical Society of America
OCIS codes: (170.3660) Light propagation in tissues; (170.6280) Spectroscopy, ﬂuorescence
and luminescence.
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1. Introduction
Fluorescence imaging is widely used for measuring functional and structural parameters which
cannotbeeasilyimagedusingendogenoussourcesofcontrast.Thespeciﬁcusesofﬂuorophores
and phosphors in vivo vary widely; a few examples include applications such as molecular
imaging, cancer imaging, and functional imaging of hemodynamic properties [1]. Correspond-
ingly, there are a number of delivery methods for ﬂuorophores depending on the application in
question.
Several imaging methods require the topical application of ﬂuorophores, and subsequent
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dye (VSD) imaging, which is often used to image changes in membrane potential [2]. When
not considering the genetically expressed protein variants, these methods are inherently limited
by both the capability of the ﬂuorophore to diffuse through the tissue, and the need to excite
the ﬂuorophore and measure the emission through the highly turbid tissue media. However, as
these agents distribute themselves in the tissue via diffusion, predicting the distribution of the
agent in the tissue can typically be done through the diffusion equation [3].
Intravascular contrast agents do not suffer from the need to diffuse through tissue, as they can
be administered intravenously. However, imaging is more difﬁcult to model mathematically as
the ﬂuorophore is no longer distributed in a smooth gradient, as is generally the assumption
with topically applied contrast agents. Several analytical methods have been used to model
photon migration in an in vivo ﬂuorescence imaging context. All of these methods treat the
tissue as a homogeneous medium, or a series of homogeneous layers, where transport theory
determinesthedepthandresolutionofimaging[3–5].Thesemethodsarenotintendedtopredict
ﬂuorescence emission when the ﬂuorophore distribution is determined by the vasculature.
As such, the purpose of our paper is to analyze the depth dependence of the measured signal
in intravascular ﬂuorescence imaging using two common dyes: Pd-porphyrin based phospho-
rescence [6] and indocyanine green (ICG) [7]. The Pd-porphyrin considered here is an oxygen
sensitive phosphorescent probe which has excitation maximas at 415 and 524 nm, and an emis-
sion maximum at 690 nm [6]. This probe is widely used for measuring intravascular oxygen
tension in vivo [8–10]. ICG is a ﬂuorescent probe used to image blood vessel perfusion in a
number of surgical applications [12], and has an absorption maximum in plasma at approx-
imately 800 nm, and an emission maximum at 880 nm. While these dyes are speciﬁc, their
excitation and emission wavelength optical properties are comparable to many other intravas-
cular contrast agents.
We have developed aMonte Carlomodel whereby ﬂuorescence emission can be modeled ina
realistic in vivo geometry using excitation and detection schemes currently being used [13–15].
The model is used to determine the differences in ﬂuorescence emission distribution between a
realistic microvasculature geometry and a homogeneous tissue geometry. The model is further
used to demonstrate the origin of ﬂuorescence emission under several different illumination and
detection schemes, and then to study intra-vessel distribution of ﬂuorescence emission based
on the excitation wavelength.
Recent work by Tian et. al. [16] used Monte Carlo simulations to study spatial resolution
and depth dependent sensitivity to perturbations in both ﬂuorescent and non-ﬂuorescent two
dimensional imaging using a homogeneous tissue geometry. Our work, however, focuses on
the origin and spatial distribution of detected ﬂuorescence which originates speciﬁcally in the
vasculature.
2. 3D ﬂuorescence Monte Carlo model
The model uses a 3D ﬂuorescence Monte Carlo method to evaluate an illumination and de-
tection scheme in an arbitrary geometry [17, 18]. Similar non-ﬂuorescence based modeling
techniques [19] have been used to study port-wine stain in an epidermal geometry obtained via
optical coherence tomography [20]. Geometries are speciﬁed by setting tissue optical properties
in a 3D voxelized grid. Optical properties for each voxel can be speciﬁed for both the excitation
light and the emitted light. The modeled excitation photons scatters through the tissue and can
either be absorbed in a voxel, whereby an emission event may occur, or terminated if it reaches
the boundary of the geometry. Emission photons originate from the location of absorption and
are emitted isotropically. The emitted photons can then either scatter or be absorbed based on
an independent set of emission optical properties.
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The optical properties of Pd-porphyrin, ICG, blood and gray matter were used in this model.
The Monte Carlo model allowed for an arbitrary 3D voxelized geometry, where each voxel
could represent one of up to 255 different sets of optical properties (ma, ms, g). Quantum efﬁ-
ciency can be set for the emission optical properties, which determines the likelihood of ﬂuo-
rescence or phosphorescence emission upon absorption of an incident excitation photon.
The model geometry was derived from in vivo images of mouse cortical vasculature. Scan-
ning two-photon ﬂuorescence microscopy was used to generate depth-resolved stacks of mi-
crovasculature in a mouse (CD-1; male, 25 - 30 g). All experimental procedures were approved
by the Institutional Animal Care and Use Committee (IACUC) at the University of Texas at
Austin. The animals were anesthetized by inhalation of 2.3% isoﬂurane in oxygen through
a nose cone. Body temperature was maintained at 37◦ C using a feedback controlled heat-
ing plate (ATC100, World Percision Instruments, Sarasota, FL, USA) during the experiment.
The animals were ﬁxed in a stereotaxic frame (Kopf Instruments, Tujunga, CA, USA) and an
3mm x 3mm portion of the skull was removed using a dental burr (IdealTM Micro-Drill, Fine
Science tools, Foster City, CA, USA). 50mL of 5% weight/volume Texas Red (Invitrogen, Eu-
gene, OR, USA) was administered through a retro-orbital injection to label the vasculature. A
500mm×500mm image was taken in 2mm z-steps down to 400mm. The geometry for the
Monte Carlo model was then created by ﬁltering the images to smooth out heterogeneities in
the vasculature, interpolating to attain images at every 1mm and thresholding the images to
generate a 500x500x400 voxel binary geometry. Each voxel was assigned a set of excitation
and emission optical properties based on whether it represented extravascular or intravascular
space. Fig. 1(a) shows the two-photon stack used to generate the geometry.
The intravascular absorption coefﬁcients were generated based on the extinction coefﬁcients
of hemoglobin and Pd-porphyrin/ICG. Concentrations of hemoglobin and Pd-porphyrin in the
vasculature were assumed to be 2.3 mM [21] and 0.1 mM [13] respectively. The concentration
of ICG was 0.13 mM. Scattering coefﬁcients were interpolated from measurements done by
Bevilacquaetal.[22]andFriebeletal.[23].Extravascularabsorptionandscatteringcoefﬁcients
were based on the in vitro measurements by Yaroslavsky et al. [24]. It was necessary to use in
vitro measurements of the extravascular tissue because blood was assumed to only be present
in intravascular space. The in vitro measurements were taken in the absence of blood. The
(a) (b)
Fig. 1. (a) 500mm by 500mm by 400mm microvasculature image stack acquired in a CD-
1 mouse brain by two-photon scanning microscopy. (b) Single vessel geometry. Red area
represents vessel, blue area represents bulk-vascularized space.
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artifactofexvivomeasurements.Thequantumefﬁciencywassetto1fortheintravascularspace
and 0 for the extravascular space. Though realistically the quantum efﬁciency would be 5-10%,
the model allowed for 100% conversion of absorbed excitation photons to emission photons
in the ﬂuorescing region to increase computational efﬁciency. Using this model for quantum
efﬁciency is accurate when a single ﬂuorophore is present in the model, and the concentration
of ﬂuorophore is the same in all regions containing the ﬂuorophore. Table 1 lists the optical
properties used for the microvasculature geometry.
Homogeneous tissue geometries were also created to compare against the realistic geometry.
These geometries were created by using a 500×500×400 voxel geometry where all voxels
were assigned the same properties. Optical properties were assigned by assuming that the only
absorber was blood mixed with ﬂuorescent dye, the same assumption made for the intravascular
properties in the microvasculature geometry. The properties were then scaled by 0.01, 0.05
and 0.10 to represent a bulk-vascularization assumption of 1%, 5% and 10% respectively. The
microvasculature geometry used contained approximately 3.5% vascularization, so the chosen
bulk-vasculature amounts of 1%, 5% and 10% provide a range of approximattions that can be
used for comparison.
Additional geometries were created to determine the effect of targeting a single vessel. A
3mm×3mm×3mm cubic geometry with a single vessel running down the top center was cre-
ated, as shown in Fig. 1(b). The size of the vessel was varied from 25mm to 200mm in 25mm
increments. The intra-vessel optical properties were set according to the values listed in Table
1. Outside the vessel, the tissue was assumed to be homogeneous with a bulk volume fraction
of approximately 5%.
2.2. Fluorescence Monte Carlo
A 3D ﬂuorescence Monte Carlo model was used where photons enter the 3D voxelized geom-
etry in a user speciﬁed location, beam radius and numerical aperture. Each voxel is assigned
Table 1. Optical properties for microvasculature geometry
ma (mm−1) ms (mm−1) g
Pd− porphyrin
415 nm
Intravascular 280 180 0.98
Extravascular 0.5 14 0.9
524 nm
Intravascular 16.3 120 0.98
Extravascular 0.1 11.3 0.9
690 nm
Intravascular 0.2 100 0.98
Extravascular 0.1 10 0.9
ICG
800 nm
Intravascular 3.75 124 0.98
Extravascular 0.1 12.4 0.9
880 nm
Intravascular 0.7 130 0.98
Extravascular 0.1 13 0.9
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photons is handled as an all-or-nothing event to provide a speciﬁc location for emission photon
generation. If an excitation photon is absorbed, then a ﬂuorescence photon may be generated
depending on the quantum efﬁciency of the tissue type, or voxel, where the photon was ab-
sorbed.
Upon creation, the ﬂuorescence photon is emitted isotropically from the point where the
excitation photon was absorbed. The model then uses emission optical properties to specify
the scattering and step sizes of the ﬂuorescent photons. Absorption is not calculated at each
emission photon move location, but is instead applied during post-processing [17,25]. For each
ﬂuorescence photon that exits the tissue within the speciﬁed detector area and NA, the total
path length traveled in each tissue type is recorded. In post processing, the contribution to the
detected signal from photons originating at a point inside the tissue (x,y,z) is calculated as:
Id(x,y,z) =å
j
e−åi mi
alij (1)
where j represents the photons originating at point (x,y,z) in the tissue, and i represents the
tissue type inside the geometry. The distance each photon travels within each tissue type, lij,
and the absorption coefﬁcient, mi
a, in each tissue type is used to generate the weight of each
photon using Beer’s law. In our simulations, two tissue types were used: vasculature and non-
vasculature. Therefore, the total travel lengths in vascular (l1), and non-vascular (l2) were saved
for each detected ﬂuorescent photon. This process is repeated for every point inside the geom-
etry to build up a three dimensional distribution of signal using photons which arrive at a user
speciﬁed detector location.
The depth-dependent signal distribution, f(z), which is the probability of the collected signal
originating from a depth z in the geometry, was calculated from the signal intensity distribution
Id(x,y,z) using the following relation:
f(z) =
ZZ
Id(x,y,z)dxdy
ZZZ
Id(x,y,z)dxdydz
(2)
The depth-integrated signal distribution, F(z) can then be calculated by integrating f(z) from
0 to z, and represents the amount of signal originating from the ﬁrst z in the geometry. The
expression for F(z) is as follows:
F(z) =
Z z
0
f(z)dz (3)
2.3. Simulations
2.3.1. Comparison of microvasculature and homogeneous geometry
Our ﬁrst consideration was to analyze the difference in the spatial distribution of the origin
of emission between an in vivo microvasculature geometry, and the more typically used as-
sumption of homogeneous tissue with a volume fraction of absorbers. In the microvasculature
geometry, a wide ﬁeld illumination and small detection area method was simulated to mimic a
single pixel in a typical camera geometry. A 400mm diameter, slightly diverging (NA = 0.01)
cone of light on the surface of the tissue geometry was used as the illumination. The detector
was a 50mm×50mm square at the top-center of the geometry, which is intended to act simi-
larly to a pixel in a camera. Imaging techniques which rely on a full surface illumination and a
camera for detection operate on a similar principle. The small detection volume can be thought
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referred to as the “camera” scheme.
For each of the three homogeneous tissue geometries, 1%, 5%, and 10% blood volume frac-
tion, simulations were performed using 415 nm, 524 nm, and 800 nm excitation. Absorption
coefﬁcients in homogeneous areas were set to the intravascular absorption coefﬁcient scaled
by the volume fraction. Quantum efﬁciency was set to 1, as blood was assumed to be the only
absorber. The signal intensity as a function of depth was calculated from the results of the
simulation, in addition to the cumulative distribution function. As with the microvasculature
geometries, the camera scheme was used for illumination and detection. f(z) and F(z) were
calculated from the signal distribution, Id(x,y,z) using Eqns. (2) and (3), and used to compare
the homogeneous and microvascular geometries. The effect of detector position on f(z) and
F(z) was also investigated at each excitation wavelength by comparing two areas with small
pial vessel clusters and one area containing a larger 25mm diameter vessel directly on the sur-
face of the microvasculature geometry.
2.3.2. Evaluation of different illumination and detection schemes
For each excitation wavelength (415 nm, 524 nm and 800 nm), the microvascular geometry
was used for three illumination and detection schemes. The camera illumination and detection
scheme described previously was used for the comparison, in addition to two other methods:
the “targeted” scheme, and the “confocal” scheme.
The “targeted” method consisted of a 20mm diameter illumination area and a detector that
captured all emission photons exiting the surface of the tissue. This scheme mimics selective
illumination of a small area of the tissue and integration of all ﬂuorescent photons exiting the
tissue, similar to approaches that utilize structured excitation with single point detectors [13].
The third method was a hybrid of the previous two, which is similar to the scanning confocal
method. The illumination source was a 20mm diameter beam with an NA of 0.01, while the
detector was a 50mm×50mm square at the top-center of the geometry. While this method
does not mimic true confocal imaging, it does combine small-area illumination with a detector
intended to reject light from areas away from the focal volume. As such, we will refer to this
method as the “confocal” illumination and detection scheme.
The results of the three illumination schemes were then compared to determine the effect of
choosing a targeted illumination scheme over a wide-ﬁeld illumination scheme, as well as a
wide area detector (i.e., PMT or APD) over a small area detector (i.e., camera pixel) based on
the desired signal distribution.
To provide a comparison between the schemes, both the depth-dependent and depth-
integrated signal distributions for each excitation and emission wavelength pair were calculated
according to Eqns. (2) and (3). Additionally, the 3D rendering of the signal distribution for the
camera scheme, Id(x,y,z), was generated and overlaid on the maximum intensity projection
of the microvasculature geometry to demonstrate the effects of using a wide ﬁeld illumination
method.
2.3.3. Evaluation of ﬂuorescence sampling in single vessels
The objective of the single vessel geometry was to determine the penetration of excitation
light into underlying tissue when ﬂuorescence is measured from surface vessels, and thus to
determine how much of the captured signal can be attributed to the targeted vessel. As such, the
illumination area was a circle with a diameter that matched the diameter of the vessel in each
geometry. Vessel diameters of 25, 50, 75, 100, 150, and 200mm were used, which represents
approximately the range of vessel diameters in the rat cortex, excluding capillaries, precapillary
arterioles, and postcapillary venules. Simulations were performed using 415 nm, 524 nm and
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vascularization was used so that a measure of the amount of excitation light penetrating through
the vessel could be easily measured. The portion of the signal Id(x,y,z) inside the vessel was
divided by the total integrated signal to obtain a value representing the percentage of signal
originating from inside the single targeted vessel.
3. Results
3.1. Comparison of microvasculature and homogeneous geometry
The comparison between the microvasculature geometry and the homogeneous tissue geometry
can be seen in Fig. 2. The top row of Fig. 2 shows the depth-dependent signal distribution, f(z),
of the collected signal, calculated using Eq. (2). The bottom row of Fig. 2 shows the depth-
integrated signal distribution, F(z), of the collected signal as a function of depth–a value of 0.3
at 100mm, therefore, would mean that 30% of the ﬂuorescence signal originated from the top
100mm of the geometry.
For reference, measurements of the volume of the microvasculature geometry showed that
the approximate volume fraction of blood vessels was 3.5%. Homogenous geometries of 1%,
5%, and 10% for 415 nm and 524 nm excitation and 5% and 10% for 800 nm excitation are
shown to demonstrate that the results do not match a realistic geometry in most cases. The
results suggest that the accuracy of a bulk-vascularized tissue assumption is strongly dependent
on the excitation wavelength of the ﬂuorophore.
The 415 nm excitation case shown in Fig. 2(a-b) shows that the microvasculature geometry
model falls between the 1% and 5% homogeneous geometry. The 50mm×50mm detector
location is positioned in the center of the illumination ring. The area contains a pial vessel at
approximately 40mm inside the tissue, which explains the peak at 40mm in the plot of f(z).
524 nm and 800 nm excitation produced different results. Fig. 2(c-d) shows that with 524
nm excitation the microvasculature geometry simulation gives a depth-dependent signal dis-
tribution less than that of even a 10% vacularized homogeneous tissue geometry. While the
524 nm excitation still shows shallower penetration than would be expected given the 3.5%
vascularized geometry used, the error is less dramatic than the 800 nm case. 800 nm excitation
with 880nm emission, shown in Fig. 2(e-f) again produced the opposite result from the 415 nm
excitation, where the depth penetration is signiﬁcantly less than what would be expected.
Fig. 3 shows the depth-dependent and depth-integrated signal distributions corresponding to
detector locations marked in the maximum intensity projection of the microvasculature stack at
(a-b) 415 nm, (c-d) 524 nm and (e-f) 800 nm excitation wavelengths. The two regions chosen
which contained small pial vessels, marked in blue and green, had similar depth-integrated
distributions. When the detector was positioned over the larger 25mm diameter surface vessel,
the depth-dependent and depth-integrated distributions were strongly weighted towards the ﬁrst
25mm in the geometry. Approximately 65% of the collected signal originated from the ﬁrst
25mm using 415 nm and 524 nm excitation, and 53% of the signal originated from the same
region at 800 nm. From the depth-dependent distribution at 415 nm excitation shown in ﬁg.
3(a), the ﬁrst 60% of the signal originates from the top 5mm of the surface vessel, while the
remaining 20mm of vessel contributes the other 5% of the signal. At both 524 nm and 800 nm,
however, the signal is distributed evenly throughout the surface vessel.
3.2. Evaluation of different illumination and detection schemes
Figure 4 shows the depth dependence of the detected signals for the three imaging geome-
tries. Fig. 4(a-b) shows the depth-dependent and depth-integrated signal distributions in the
microvasculature geometry using the camera illumination and detection scheme at 415 nm, 524
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Fig. 2. f(z) and F(z) of collected signal using homogeneous, bulk-vascularized tissue as-
sumption and comparison to the camera illumination and detection scheme using (a-b) 415
nm, (c-d) 524 nm and (e-f) 800 nm excitation. Note that the x-axis in (a-b) is different from
(c-f).
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Fig. 3. f(z) and F(z) of collected signal using the camera illumination and detection
scheme at different detector positions using (a-b) 415 nm, (c-d) 524 nm and (e-f) 800 nm
excitation. Note that the x-axis in (a-b) is different from (c-f).
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Fig. 4. (a) Depth-dependent, f(z), and (b) depth-integrated, F(z), signal distribution for the
targeted illumination and detection scheme; (c) and (d) are f(z) and F(z) using the camera
scheme, and (e) and (f) are f(z) and F(z) using the confocal scheme.
nm and 800 nm excitation. Fig. 4(c-d) shows f(z) and F(z) when using a wide-ﬁeld illumina-
tion method with a small detection area on the surface of the tissue, and Fig. 4(e-f) shows f(z)
and F(z) in the case of the confocal illumination and detection scheme.
From Fig. 4(e-f), the best spatial localization is obtained when using the confocal illumina-
tion and detection scheme. The strong peak at approximately 40mm in the plots on the bottom
row represents an approximately 20mm wide vessel directly below the surface position of the
illumination beam and the center of the detector.
Using the targeted scheme, shown in Figs. 4(a-b), generates a strongly wavelength-dependent
signal distribution. When using 415 nm excitation, the signal distribution is similar to the dis-
tribution obtained when using the confocal illumination and detection scheme. However, when
524 nm or 800 nm excitation light was used, the ﬁrst vessel encountered did not represent a
signiﬁcant fraction of the total measured signal.
Lastly, the camera scheme shown in Fig. 4(c-d), is the least sensitive method of the three
to surface vasculature, with only a small fraction of the total collected signal originating from
directly under the detector area.
Asavisualaide,Fig.5showstheoriginofﬂuorescencedetectedinasmallareaonthesurface
when using the camera illumination and detection scheme, overlaid on top of the maximum
intensity projection of the microvasculature stack. The simulation demonstrates that when a
large area on the surface is illuminated, the ﬂuorescence signal collected at the surface can
originate not only from deeper in the tissue under the detector area, but also from areas near the
surface that are not under the detector: similar to what is seen with source-detector separations.
A 50mm×50mm×100mm section of the tissue below the detector was evaluated to deter-
mine how much of the signal originated from ﬂuorescent photons emitted from 100mm below
the 50mm×50mm detector. At 415 nm, 33.2% of the ﬂuorescence originated from 100mm be-
low the detector surface. At 524 nm, 15.6% originated in that area, and at 800 nm, 13.2% of the
ﬂuorescence originated within the region. When comparing these results to the total amount of
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Fig. 5. 3D rendering of ﬂuorescence signal distribution using the camera illumination and
detection scheme for (a) 415 nm, (b) 524 nm and (c) 800 nm excitation. Note that the scale
bar in (c) is different from (a) and (b).
ﬂuorescence originating from the ﬁrst 100mm of tissue, the fraction of ﬂuorescence originating
from below the detector is approximately 50% in all three cases.
3.3. Intra-vessel distribution of ﬂuorescence emission
Fig. 6 shows the results of single vessel geometry simulations at 524 nm and 415 nm illumina-
tion. Figs. 6(a) and 6(b) show a simulation result when the vessel size was set to 100mm. The
3D distribution of the signal, Id(x,y,z) was integrated along the length of the vessel to generate
the images in Figs. 6(a) and 6(b). A ﬁgure demonstrating single vessel penetration of 800 nm
excitation light is not shown, as it visually appears similar to the 524 nm excitation case. Fig.
6(c) shows the fraction of the total collected signal which originated inside the 100mm vessel at
each of the three excitation wavelengths. A targeted surface vessel with a diameter of 100mm,
for example, will produce a signal that is 100% representative of the vessel ﬂuorescence at 415
nm, 80% representative of vessel ﬂuorescence at 524 nm, and 50% representative of vessel
ﬂuorescence at 800 nm.
4. Discussion
4.1. Comparison of microvasculature and homogeneous geometry
From Fig. 2, we found that the microvasculature geometry simulations produce signiﬁcantly
different results than the homogeneous tissue geometry except when considering the camera
scheme. Additionally, the excitation wavelength is important when considering how the mi-
crovasculaturegeometryisdifferentfromthehomogeneousgeometry.Using415nmexcitation,
as in Fig. 2(a-b), the homogeneous geometry appears to reasonably predict the depth-integrated
distribution of the ﬂuorescence signal. However, when upon changing the detector location, as
in 3(a-b), it is shown that this is only the case when the detector is positioned over clusters
of small pial vessels. When a the detector is positioned over a larger surface vessel, the signal
is strongly weighted toward the surface. When 524 nm and 800 nm excitation were used, as
in Fig. 2(c-f), the homogeneous geometry over predicted the depth distribution of the emitted
ﬂuorescence. Positioning the detector over surface vessels, shown in 3(c-f) only increased the
amount of signal originating from the surface of the geometry.
The strongest contributor to f(z) and F(z) appears to be the actual physical distribution
of vessels at the detector location. When the detector is positioned over an area containing
several small pial vessels, the collected signal does not appear to be signiﬁcantly weighted
towards any particular depth in the tissue. When the detector is positioned over a larger surface
vessel, however, the depth-dependent distribution is strongly weighted towards the location
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Fig. 6. 100mm single vessel geometry with (a) 415 nm targeted illumination and (b) 524
nm targeted illumination. Color represents the log of the signal distribution in each 1mm×
1mm pixel. (c) Amount of detected signal originating from inside the vessel as a function
of vessel diameter.
of the surface vessel. This difference signiﬁcantly shifts the depth-integrated distribution of
the collected signal towards the surface, and causes the homogeneous geometry assumption to
predict the depth penetration even worse than it does when the detector is over smaller pial
vessels.
Differences in signal distribution between the microvasculature geometry and the homoge-
neous tissue geometry can be partially attributed to the large difference between the intra and
extra vascular absorption coefﬁcients. Excitation photons experience a small amount of ab-
sorption outside of the blood vessels, which allows them to scatter around blood vessels and
penetrate deeper into the tissue. The emission photons, being stokes-shifted into the near in-
frared region for the ﬂuorophores considered here, are not strongly absorbed in any tissue and
can return to the surface without much attenuation from absorption.
Additionally, it appears that when positioning the detector over areas containing clusters of
small pial vessels, the depth of penetration in a realistic geometry relative to the homogeneous
geometry assumption correlates with the amount of difference between the absorption of blood
andcontrast agent attheexcitation wavelength and theemissionwavelength. Alargeexcitation-
emission absorption difference, such as the 415 nm to 690 nm in Pd-porphyrin, causes the
depth penetration to be reasonably predicted by the homogeneous geometry assumption. When
there was a smaller difference, as in the 524 nm and 800 nm excitation cases, the homogeneous
tissueassumptionsigniﬁcantlyover predictsthedepthofthecollected signaldistribution.These
results are likely unique to the case of intravascular ﬂuorophore distributions and have little
bearing on previous numerical studies, where the ﬂuorophore is distributed via diffusion into
the tissue [16].
4.2. Evaluation of different illumination and detection schemes
Given the results seen confocal type illumination and detection scheme in 4(e-f), it appears that
given a low numerical aperture (NA) beam, surface vasculature can be strongly emphasized by
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In the targeted illumination scheme, shown in 4(a-b), the fraction of signal originating from
the ﬁrst vessel encountered was highly dependent on the excitation wavelength. This obser-
vation could be useful if stronger sensitivity to surface vasculature is desired, as this can be
controlled somewhat with selection of excitation wavelength. With Pd-porphyrin, either the
surface vasculature can be emphasized by using 415 nm excitation light, or higher depth sensi-
tivity can be obtained by using 524 nm excitation light. Unlike with the camera scheme shown
in 3, both the confocal and targeted schemes are able to emphasize the surface-most vessels
even when they are small and not directly on the surface.
Regardless of the excitation wavelength used, the light entering the detector in the camera
scheme is not representative of the surface-most vessels below the detector area. This is an
important observation, as often the surface vasculature will be visible on the camera which is
detecting the ﬂuorescence, and it is easy to mistake the signal received as coming from the
surface vessels. Fig. 5 provides a good visual aid to explain the peaks in Fig. 2(c). The peaks
at the surface correspond to the signal detected from the surface vasculature under the entire
illumination area, while the peaks at 40mm correspond to the ﬁrst vessel directly beneath the
detector surface. From the results found by analyzing the 50×50×100mm box below the
detector, the ﬂuorescence originating from below the detector accounts for approximately half
of the total ﬂuorescence detected from the ﬁrst 100mm, regardless of the wavelength used. The
remainder of the signal originates from areas deeper than 100mm, as well as in the ﬁrst 100mm
of tissue but outside the 50mm×50mm detector area.
From Fig. 4, the results suggest that techniques which prioritize accurate imaging of mi-
crovasculature should aim to focus the excitation light on the tissue of interest. If the excitation
light has a small NA (nearly collimated), then the emitted light will represent vasculature at a
number of different depths, dependent on the distance between the surface and the ﬁrst vessel
the excitation light meets. In many of the cases in Fig. 4, for example, the excitation pho-
tons scatter down to 40mm before encountering a blood vessel. Penetration depth is therefore
a difﬁcult subject to speak about in absolute terms, as it strongly depends on the location of
the vasculature in relation to the source excitation beam. Techniques that utilize depth selec-
tion independently of illumination, such as confocal methods, would beneﬁt from taking this
observation into consideration.
4.3. Intra-vessel distribution of ﬂuorescence emission
At 415 nm, seen in Fig. 6(c), the intra-vessel absorption was high enough to completely prevent
the excitation light from penetrating through to deeper tissues. The absorption also prevented
the excitation light from being able to sample the entire vessel. This could affect measurements
where an average across the vessel diameter would provide a more accurate measurement of
a given parameter than just the value near the vessel wall. The 524 nm illumination light was
able to sample the entire vessel, but at smaller vessel sizes the light also penetrated through the
vessel and sampled a signiﬁcant amount of tissue outside the vessel in question. At 800 nm,
the results are similar to what to the 524 nm excitation case in Fig. 6(b), though as expected
more light is able to penetrate through the vessel. Note that while these results demonstrate that
using 415 nm illumination can allow for strong emphasis of surface vasculature in the targeted
illumination scheme, Fig. 4 also suggests that using this wavelength can allow for emphasized
surface vasculature in all three of the illumination and detection schemes evaluated. It is worthy
to note, however, that lower excitation wavelengths are associated with increased phototoxicity,
as well as excitation of endogenous ﬂuorescence.
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In this paper, we showed that using a homogeneous geometry assumption to approximate the
depth-distribution of the collected ﬂuorescence signal is not an accurate for vascular ﬂuores-
cence measurements. A more complex model, involving the size, concentration and position
of the microvasculature being imaged, the difference in absorption between the excitation and
emission wavelengths, and the difference in absorption coefﬁcients in the ﬂuorescing region
compared to the non-ﬂuorescing region is required to provide a more accurate picture of depth
penetration.
We also examined three illumination and detection schemes used in ﬂuorescence imaging.
The targeted and confocal illumination schemes offer a more focused signal distribution over
wide ﬁeld illumination. Using the confocal illumination and detection scheme in particular of-
fers very strong localization of signal to the surface vasculature, while the wide-area detection
in the targeted scheme can provide more depth-weighted signals. Using the camera scheme
offers the greatest depth weighting of the three illumination and detection schemes we evalu-
ated, but at the cost of including ﬂuorescence from near the surface over the entire illumination
region.
Lastly, we examined intra-vessel sampling and demonstrated that when using an excitation
wavelength that is strongly absorbed by blood, our collected signal originates from only the
top-surface of the targeted vessels. This may need to be taken into account if using a lifetime
imaging method that will produce different results near the vessel walls–a wavelength which is
absorbed by blood less may be more useful to provide a signal which is integrated across the
vessel diameter.
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